CIGB-247 is a novel cancer therapeutic vaccine that uses a mutated form of human vascular endothelial growth factor (VEGF) as antigen in combination with the oil-free adjuvant VSSP (very small sized proteoliposomes of Neisseria meningitidis outer membrane). The vaccine was designed to affect tumor neo-vascularization and tumor cell viability by eliciting antibodies that block the inte... https://www.ivoryjinelle.com/limited-value-Hunting-Camo-iPhone-SE-2nd-3rd-Gen-Pro-Case-p79729-hot-value/